Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

What’s new in smart pens and caps for capturing injection doses? Plus, two cool new health apps with built-in artificial intelligence
The lame food advice at Adam Brown's diagnosis, why it didn’t work, and Adam's #1 Bright Spot solution
What it’s about, how to get a free copy, and three myths I want to bust
iPhone users will be able to share insulin dose data between apps, paving way for ecosystem with smart pens and connected pumps
Research presented at EASD 2017 showcased drugs, both new and old, that improve blood sugar management, weight loss, heart health, and even blood pressure
Get your copy at diaTribe.org/BrightSpots for free or name-your-own-price
Kerri Sparling on what it’s like to (attempt) balance raising young kids with managing diabetes – and how kids can be the best diabetes motivators
How to overcome the most frustrating diabetes landmine
Major win to complement Lilly’s partnership with Dr. Ed Damiano and the Bionic Pancreas team; insulin-only pivotal trial in late 2017/early 2018
New CONCEPTT trial results show improved newborn health and more time-in-range in women with type 1 diabetes using CGM during pregnancy
Physicians, diabetes educators, and research scientists share their own health bright spots in food and exercise, technology, and more
If you have a Fitbit, check out the diabetes communities in the app for tips and support from fellow people with diabetes
New dose adjustment recommendations for adults and children using Dexcom's G5 CGM based on trend arrows and insulin sensitivity
Dexcom G6 cleared by FDA with no fingerstick calibrations, 10-day wear time, approval for ages 2 years and older, no acetaminophen interference, and more
As early as 2019, the FDA could approve SGLT-2 inhibitors for adults with type 1, but some patients are already using these pills “off label”; see guidance from leading...
Toujeo Max SoloStar will launch later this year in the US. It holds 900 units of insulin and can dose up to 160 units in one injection, meaning fewer refills and...
Ultra-slim patch supports convenient mealtime insulin dosing; wearers just hit two buttons simultaneously to deliver 2 units at a time; acquired by CeQur as J&J...
Experts and innovators from all corners gathered to share the latest in new technology and treatments for people with diabetes, focusing on improving CGM and outcomes...
ADA is around the corner, and there’s going to be exciting updates on diabetes drugs and therapy, devices, big picture questions, #beyondA1C, and advocacy; stay tuned!
A unique mindset to resist tempting foods, including in peer-pressured group settings

Pages